EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

1,25-Dihydroxyvitamin D Induces a NURR1–Tyrosine Hydroxylase Transcriptional Axis Modulated by Rexinoid/RXR Signaling in Parkinson’s Disease-Relevant Human Neural Cell Models

Michael A Sausedo, Sanchita Mallick, Zhela L Sabir, Sarah Livingston, Quang T Nguyen, Mobin Emran Doost, Carl E Wagner, Pamela A Marshall iD, Carol A Haussler iD, Mark R Haussler iD, Peter W Jurutka iD

Cells · 03.07.2026 · 15 (13) · 1210

DOI: 10.3390/cells15131210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 03.07.2026. Verfasst von Michael A Sausedo und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematical and Natural Sciences, Arizona State University, Glendale, AZ 85306, USA. Hauptthemen laut MEDLINE: Nuclear Receptor Subfamily 4, Group A, Member 2, Tyrosine 3-Monooxygenase, Vitamin D, Signal Transduction. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hormonal vitamin D metabolite, 1,25-dihydroxyvitamin D (1,25D), produced primarily in the kidney, acts in numerous end-organs via the nuclear vitamin D receptor (VDR) to trigger molecular events that orchestrate bone mineral homeostasis, immune responsiveness, and aspects of behavior. Tyrosine hydroxylase (TH) encodes a neuronally expressed enzyme that catalyzes the initial, rate-limiting step in the production of several catecholamine neurotransmitters and hormones, including dopamine, norepinephrine, and epinephrine. Herein we report that TH mRNA is significantly induced (2.5-fold) and NURR1 mRNA is induced 9.3-fold by 10 nM 1,25D in differentiated human SH-SY5Y neuroblastoma cells. Similar results were observed in human U87 glioblastoma cells (TH, 2.6-fold; NURR1, 3.6-fold). Comparative analysis of TH gene promoter-proximal sequences from human, mouse, and rat identifies candidate NURR1-responsive elements (NBREs) at the following positions: −35, −855, −1470, and −2343 bp in the human gene; −34 and −961 bp in the mouse gene; and −34, −350, and −873 bp in the rat gene, consistent with NURR1 acting as a recurring regulatory factor at TH promoters across mammalian species. Furthermore, by interrogating VDR ChIP-seq/cistrome datasets, we identified candidate vitamin D-responsive elements (VDREs) at the human NURR1 locus that provide a plausible genomic framework for direct regulation of NURR1 by 1,25D/VDR. We propose that 1,25D-liganded VDR acts as a primary inducer of NURR1, which in turn secondarily activates expression of the TH gene, thereby defining a transcriptional route through which 1,25D/VDR signaling may influence TH-linked dopaminergic gene programs. Retinoid X receptor (RXR) may facilitate both NURR1-dependent and -independent potentiation of TH transcription because the rexinoid, bexarotene, significantly enhances TH mRNA in human U87 cells, either alone (2.0-fold) or in combination with 1,25D (4.1-fold). In addition, bexarotene and its novel analogs, A41 and A55, induce NURR1 mRNA expression in U87 cells by 2.8-, 3.1-, and 4.8-fold, respectively, with A55 outperforming the parent compound at matched concentration. Because Parkinson’s disease is characterized by the selective degeneration of dopaminergic neurons and impaired NURR1-dependent transcriptional programs, our findings identify a 1,25D/VDR–NURR1–RXR transcriptional axis as a previously underappreciated regulatory framework for studying TH gene expression and dopaminergic gene regulation in Parkinson’s disease-relevant neural contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear Receptor Subfamily 4, Group A, Member 2Tyrosine 3-MonooxygenaseVitamin DSignal TransductionRetinoid X ReceptorsParkinson DiseaseTranscription, GeneticNeuronsHumansAnimalsCell Line, TumorReceptors, CalcitriolPromoter Regions, GeneticMiceRNA, Messenger

Stichwörter der Autor:innen

NURR1Parkinson’s diseaseRXR/VDRdopaminergic neuronsgene expressionrexinoidstyrosine hydroxylasevitamin D

Substanzen

Nuclear Receptor Subfamily 4, Group A, Member 2Tyrosine 3-MonooxygenaseVitamin DRetinoid X Receptors1,25-dihydroxyvitamin DNR4A2 protein, humanReceptors, CalcitriolRNA, Messenger

Autor:innen und Institutionen

  • School of Mathematical and Natural Sciences, Arizona State University, Glendale, AZ 85306, USA.
  • College of Medicine, University of Arizona, Phoenix, AZ 85004, USA.
  • John Shufeldt School of Medicine and Medical Engineering, Arizona State University, Phoenix, AZ 85004, USA.

ORCID-Profile: Pamela A Marshall, Carol A Haussler, Mark R Haussler, Peter W Jurutka

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NIH
  • Arizona State University, Barrett the Honors College
  • New College Undergraduate Inquiry and Research Experiences
  • School of Life Sciences Undergraduate Research

Zitieren

APA

Sausedo, M. A., Mallick, S., Sabir, Z. L., Livingston, S., Nguyen, Q. T., Doost, M. E., Wagner, C. E., Marshall, P. A., Haussler, C. A., Haussler, M. R., & Jurutka, P. W. (2026). 1,25-Dihydroxyvitamin D Induces a NURR1–Tyrosine Hydroxylase Transcriptional Axis Modulated by Rexinoid/RXR Signaling in Parkinson’s Disease-Relevant Human Neural Cell Models. Cells, 15(13), 1210. https://doi.org/10.3390/cells15131210

Vancouver

Sausedo MA, Mallick S, Sabir ZL, Livingston S, Nguyen QT, Doost ME, et al. 1,25-Dihydroxyvitamin D Induces a NURR1–Tyrosine Hydroxylase Transcriptional Axis Modulated by Rexinoid/RXR Signaling in Parkinson’s Disease-Relevant Human Neural Cell Models. Cells. 2026;15(13):1210. doi:10.3390/cells15131210

BibTeX
@article{Sausedo2026,
  author = {Sausedo, Michael A and Mallick, Sanchita and Sabir, Zhela L and Livingston, Sarah and Nguyen, Quang T and Doost, Mobin Emran and Wagner, Carl E and Marshall, Pamela A and Haussler, Carol A and Haussler, Mark R and Jurutka, Peter W},
  title = {1,25-Dihydroxyvitamin D Induces a NURR1–Tyrosine Hydroxylase Transcriptional Axis Modulated by Rexinoid/RXR Signaling in Parkinson’s Disease-Relevant Human Neural Cell Models},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {13},
  pages = {1210},
  doi = {10.3390/cells15131210}
}
Kostenlos starten →